PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Update and Appendix 4C - quarterly, page-36

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    100% agree.

    There are definitely much easier targets which makes me think that the current shorts failed to cover when PAR exited the ASX 300, so they're basically stuck since they can't cover without making a sizeable loss. My view is short sellers are hoping for a capital raise so they can cover or will hope investors decide to claim a tax loss. My view is short sellers are waiting for PAR to announce when the last patient is dosed for 008, until which they start to cover since it will be far too risky for them to continue holding.

    I was always of the view that the first half of 2022 was going to be quiet, but not 2H2022.


    Last edited by Zenox: 02/05/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.